Hoffmann-La Roche: all 2,744 studies
Page 25 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled CorticosteroidsCompletedNCT00930163Phase 2
- Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based TherapyCompletedNCT00928330Phase 1
- A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease PatientsCompletedNCT00922610Phase 4
- A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid TumorsCompletedNCT00909740Phase 1
- A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00909597Phase 3
- A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid ArthritisCompletedNCT00888745Phase 1
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT00884507Phase 2
- A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast CancerCompletedNCT00882674Phase 1
- Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral NeuropathyCompletedNCT00876538Phase 2
- A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or IntolerableCompletedNCT00876122Phase 1
- A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or IntolerableCompletedNCT00876109Phase 1
- A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal CancerCompletedNCT00873756Phase 1
- A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4CompletedNCT00869661Phase 2
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00854152Phase 1
- A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00854126Phase 1
- A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)CompletedNCT00851136Phase 1
- A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerTerminatedNCT00845910Phase 2
- A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab EmtansineCompletedNCT00833963
- A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's LymphomaCompletedNCT00825149Phase 1
- A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin MonotherapyCompletedNCT00823992Phase 3
- A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of MetforminCompletedNCT00823680Phase 2
- A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney TransplantationCompletedNCT00817687Phase 4
- A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid TumorsCompletedNCT00817518Phase 1
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- A Study of Taspoglutide in Type 2 Diabetic PatientsCompletedNCT00811460Phase 1
- A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 DiabetesCompletedNCT00809705Phase 3
- A Study of RO4917523 in Patients With Treatment Resistant DepressionCompletedNCT00809562Phase 2
- A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00806923Phase 3
- A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C PatientsCompletedNCT00801255Phase 1
- A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis CCompletedNCT00800748Phase 4
- CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney TransplantsCompletedNCT00788567Phase 3
- Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV InfectionCompletedNCT00782353Phase 1
- A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent StudiesActive, not recruitingNCT00781612Phase 2
- A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic AsthmaCompletedNCT00781443Phase 2
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid ArthritisTerminatedNCT00779220Phase 2
- A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.CompletedNCT00776698Phase 1
- A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid MalignanciesCompletedNCT00776425Phase 4
- PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast CancerWithdrawnNCT00774241Phase 4
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.CompletedNCT00773526Phase 1
- A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.CompletedNCT00773331Phase 3
- A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.CompletedNCT00773188Phase 1
- A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I DiabetesCompletedNCT00772356Not applicable
- A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).CompletedNCT00760565Phase 1
- A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.CompletedNCT00755287Phase 3
- A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.CompletedNCT00754988Phase 3
- A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerSuspendedNCT00753480Phase 1
- A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00747734Phase 1
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00746317Phase 1
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.CompletedNCT00744926Phase 3
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedNCT00744367Phase 3
- A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's DiseaseCompletedNCT00736775Phase 1
- A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal TransplantationWithdrawnNCT00729768Phase 2/3
- A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.CompletedNCT00721266Phase 1
- A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid ArthritisTerminatedNCT00718588Phase 1
- A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.CompletedNCT00717821Phase 3
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.CompletedNCT00717457Phase 3
- A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative ColitisCompletedNCT00694980Phase 1
- A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia GravisCompletedNCT00683969Phase 3
- A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00682097Phase 1
- A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.TerminatedNCT00680563Phase 3
- A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal CancerCompletedNCT00671372Phase 1
- An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)CompletedNCT00669045
- Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT00666016Phase 2
- A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00664898Phase 1
- A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)CompletedNCT00661284
- A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).CompletedNCT00661102Phase 3
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedNCT00661076Phase 3
- PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)CompletedNCT00643474Not applicable
- A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on DialysisCompletedNCT00642967Phase 3
- A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.TerminatedNCT00642824Phase 2
- A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNCT00642733Phase 4
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.CompletedNCT00642577Phase 3
- Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) PatientsCompletedNCT00628043Phase 3
- A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.CompletedNCT00623870Phase 1
- A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.CompletedNCT00616798Phase 2
- INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.CompletedNCT00615134Phase 2
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.CompletedNCT00614471Phase 4
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.WithdrawnNCT00577109Phase 2
- A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney TransplantTerminatedNCT00576602Phase 4
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.CompletedNCT00576433Phase 4
- Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal RateCompletedNCT00569452Not applicable
- A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.WithdrawnNCT00560547Phase 3
- A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.CompletedNCT00560274Phase 4
- A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.CompletedNCT00560144Phase 1
- A Study of RO5045337 [RG7112] in Patients With Advanced Solid TumorsCompletedNCT00559533Phase 1
- A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's LymphomaCompletedNCT00556699Phase 1
- BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal OsteoporosisCompletedNCT00545909Phase 4
- SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.CompletedNCT00545480Phase 4
- A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.CompletedNCT00545207Phase 3
- ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.CompletedNCT00545090Phase 4
- A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)TerminatedNCT00543712Phase 2
- A Study of rhuMAb IFNalpha in Adults With Systemic Lupus ErythematosusCompletedNCT00541749Phase 1
- A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.CompletedNCT00532090Phase 1
- A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.CompletedNCT00531804Phase 1
- A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNACompletedNCT00520273Not applicable
- A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular SurgeryStatus unknownNCT00519961Not applicable
- A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.CompletedNCT00517816Phase 1
- A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00517465Phase 1
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.CompletedNCT00517439Phase 2